SCHEMBL7529401

SCHEMBL7529401

CCCNc1cc(OC)ccc1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.66
SRC P12931 3/20 0.44
P2RX7 Q99572 1/20 0.42
HTR1A P08908 3/20 0.42
ADRA1D P25100 3/20 0.42
ADRA1A P35348 3/20 0.42
ADRA1B P35368 3/20 0.42
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
LIMK1 P53667 1/20 0.39
LIMK2 P53671 1/20 0.39
HTR2A P28223 2/20 0.39
SLC6A4 P31645 2/20 0.39
KCNH2 Q12809 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18893408 0.86 TDP1 (0.50) TDP1HTR1AADRA1DADRA1AADRA1B
SCHEMBL21635515 0.86 TDP1 (0.60) TDP1SRCP2RX7ALDH1A1GAA
SCHEMBL30106110 0.85 TDP1 (0.64) TDP1SRCP2RX7HTR1AADRA1D
SCHEMBL878052 0.85 TDP1 (0.64) TDP1SRCP2RX7HTR1AADRA1D
SCHEMBL12748233 0.85 TDP1 (0.64) TDP1SRCP2RX7HTR1AADRA1D
SCHEMBL5663443 0.81 KMT2A (0.51) ALDH1A1GAAMAPT
SCHEMBL16301339 0.81 TDP1 (0.44) TDP1P2RX7HTR1AADRA1DADRA1A
SCHEMBL19848073 0.79 TDP1 (0.43) TDP1HTR1AADRA1DADRA1AADRA1B
SCHEMBL19848147 0.79 TDP1 (0.43) TDP1HTR1AADRA1DADRA1AADRA1B
SCHEMBL9762866 0.79 TDP1 (0.64) TDP1SRCP2RX7HTR1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137740-A1 Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them FONTAINE EVELYNE (FR) 2002-09-26 US disclosed
EP-0934290-B1 AMINOTHIAZOLE DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI SYNTHELABO (FR) 2002-04-17 EP disclosed
US-6344470-B1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same SANOFI-SYNTHELABO (FR) 2002-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137740-A1 Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them CRHR1, ADRA1D, ADRB1 TDP1 4512/4885SRC 1821/4885P2RX7 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.